Healthcare

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile Initial...

Angle Health Partners with PerfectQuote to Revolutionize Level Funded Health Plan Quoting with Industry’s First Real-Time Underwritten Rates

Group Health Life and Benefits Brokers can leverage PerfectQuote's Digital Quoting Platform to receive firm, underwritten level funded quotes directly...

Citizen Health Raises $30 Million to Build AI Advocate for Every Patient, Ushering in a New Era of Patient-Centered Healthcare

SAN FRANCISCO, Aug. 14, 2025 /PRNewswire/ -- Citizen Health, a patient-powered platform transforming rare disease care, announced today it has...

error: Content is protected !!